Plasma membrane electron transport in pancreatic β-cells is mediated in part by NQO1.

Plasma membrane electron transport (PMET), a cytosolic/plasma membrane analog of mitochondrial electron transport, is a ubiquitous system of cytosolic and plasma membrane oxidoreductases that oxidizes cytosolic NADH and NADPH and passes electrons to extracellular targets. While PMET has been shown to play an important role in a variety of cell types, no studies exist to evaluate its function in insulin-secreting cells. Here we demonstrate the presence of robust PMET activity in primary islets and clonal β-cells, as assessed by the reduction of the plasma membrane-impermeable dyes WST-1 and ferricyanide. Because the degree of metabolic function of β-cells (reflected by the level of insulin output) increases in a glucose-dependent manner between 4 and 10 mM glucose, PMET was evaluated under these conditions. PMET activity was present at 4 mM glucose and was further stimulated at 10 mM glucose. PMET activity at 10 mM glucose was inhibited by the application of the flavoprotein inhibitor diphenylene iodonium and various antioxidants. Overexpression of cytosolic NAD(P)H-quinone oxidoreductase (NQO1) increased PMET activity in the presence of 10 mM glucose while inhibition of NQO1 by its inhibitor dicoumarol abolished this activity. Mitochondrial inhibitors rotenone, antimycin A, and potassium cyanide elevated PMET activity. Regardless of glucose levels, PMET activity was greatly enhanced by the application of aminooxyacetate, an inhibitor of the malate-aspartate shuttle. We propose a model for the role of PMET as a regulator of glycolytic flux and an important component of the metabolic machinery in β-cells.

[1]  S. Robinson,et al.  A role for Na+/H+ exchangers and intracellular pH in regulating vitamin C-driven electron transport across the plasma membrane. , 2010, The Biochemical journal.

[2]  J. Gray,et al.  Usurping the mitochondrial supremacy: Extramitochondrial sources of reactive oxygen intermediates and their role in beta cell metabolism and insulin secretion , 2010, Toxicology mechanisms and methods.

[3]  M. Andersen,et al.  ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. , 2010, Toxicology and applied pharmacology.

[4]  M. Berridge,et al.  Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1. , 2010, Free radical biology & medicine.

[5]  G. Cline,et al.  Role for malic enzyme, pyruvate carboxylation, and mitochondrial malate import in glucose-stimulated insulin secretion. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  G. Krenz,et al.  Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells. , 2009, Free radical biology & medicine.

[7]  M. Jensen,et al.  Metabolic cycling in control of glucose-stimulated insulin secretion. , 2008, American journal of physiology. Endocrinology and metabolism.

[8]  M. Iida,et al.  Impaired insulin secretion by diphenyleneiodium associated with perturbation of cytosolic Ca2+ dynamics in pancreatic beta-cells. , 2008, Endocrinology.

[9]  M. Berridge,et al.  The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. , 2007, Biochemical pharmacology.

[10]  M. Andersen,et al.  Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion , 2007, Diabetes.

[11]  O. Shirihai,et al.  Ca2+, NAD(P)H and membrane potential changes in pancreatic beta-cells by methyl succinate: comparison with glucose. , 2007, The Biochemical journal.

[12]  A. Lansner,et al.  A mathematical model of the mitochondrial NADH shuttles and anaplerosis in the pancreatic beta-cell. , 2007, American journal of physiology. Endocrinology and metabolism.

[13]  M. Berridge,et al.  Plasma membrane electron transport: a new target for cancer drug development. , 2006, Current molecular medicine.

[14]  M. Jensen,et al.  A Pyruvate Cycling Pathway Involving Cytosolic NADP-dependent Isocitrate Dehydrogenase Regulates Glucose-stimulated Insulin Secretion* , 2006, Journal of Biological Chemistry.

[15]  G. Krenz,et al.  Influence of pulmonary arterial endothelial cells on quinone redox status: effect of hyperoxia-induced NAD(P)H:quinone oxidoreductase 1. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[16]  R. Quintens,et al.  Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. , 2005, Diabetes.

[17]  M. Berridge,et al.  Trans-plasma membrane electron transport: A cellular assay for NADH- and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1 , 1998, Protoplasma.

[18]  Patries M Herst,et al.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. , 2005, Biotechnology annual review.

[19]  C. Newgard,et al.  Cell lines derived from pancreatic islets , 2004, Molecular and Cellular Endocrinology.

[20]  M. Berridge,et al.  Distinct trans-plasma membrane redox pathways reduce cell-impermeable dyes in HeLa cells , 2004, Redox report : communications in free radical research.

[21]  J. Lambeth NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.

[22]  P. Kugler Quantitative dehydrogenase histochemistry with exogenous electron carriers (PMS, MPMS, MB) , 2004, Histochemistry.

[23]  T. Kuhn,et al.  CNS neurons express two distinct plasma membrane electron transport systems implicated in neuronal viability , 2002, Journal of neurochemistry.

[24]  C. Dawson,et al.  Pulmonary reduction of an intravascular redox polymer. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[25]  M. Prentki,et al.  Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. , 2000, Diabetes.

[26]  M. Baker,et al.  Plasma membrane NADH-oxidoreductase system: a critical review of the structural and functional data. , 2000, Antioxidants & redox signaling.

[27]  M. Berridge,et al.  Cell-surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase. , 2000, Antioxidants & redox signaling.

[28]  H. Kasai,et al.  Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. , 1999, Science.

[29]  T. Kishi,et al.  Ubiquinone redox cycle as a cellular antioxidant defense system , 1999, BioFactors.

[30]  Jeremy Fairbank,et al.  Historical Perspective , 1987, Do We Really Understand Quantum Mechanics?.

[31]  A. Azzi,et al.  High rates of extracellular superoxide generation by cultured human fibroblasts: involvement of a lipid-metabolizing enzyme. , 1996, The Biochemical journal.

[32]  R. Zurbriggen,et al.  The plasma membrane NADH-diaphorase is active during selective phases of the cell cycle in mouse neuroblastoma cell line NB41A3. Its relation to cell growth and differentiation. , 1996, Biochimica et biophysica acta.

[33]  C. Jung,et al.  Ascorbic acid is essential for the release of insulin from scorbutic guinea pig pancreatic islets. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. J. MacDonald,et al.  Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. , 1995, The Journal of biological chemistry.

[35]  S. J. Holt,et al.  A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. , 1995, Growth regulation.

[36]  F. L. Crane,et al.  Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. J. Holt,et al.  Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. , 1995, Journal of immunological methods.

[38]  F. Vaillant,et al.  Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. , 1994, The Journal of biological chemistry.

[39]  P. Bergsten,et al.  Ascorbic acid and insulin secretion in pancreatic islets. , 1994, The Journal of biological chemistry.

[40]  F. L. Crane,et al.  A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane. , 1992, Biochimica et biophysica acta.

[41]  P. Navas,et al.  Growth factor‐stimulated trans plasma membrane electron transport in HL‐60 cells , 1992, FEBS letters.

[42]  A. Brightman,et al.  NADH oxidase of plasma membranes , 1991, Journal of bioenergetics and biomembranes.

[43]  F. L. Crane,et al.  Transplasma-membrane redox systems in growth and development. , 1985, Biochimica et biophysica acta.

[44]  F. L. Crane,et al.  Transplasma membrane redox stimulates HeLa cell growth. , 1984, Biochemical and biophysical research communications.

[45]  F. L. Crane,et al.  Properties of a transplasma membrane electron transport system in HeLa cells , 1984, Journal of bioenergetics and biomembranes.

[46]  F. L. Crane,et al.  Evidence for the extracellular reduction of ferricyanide by rat liver. A trans-plasma membrane redox system. , 1981, The Biochemical journal.